InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Biotechnology and patentability: navigating unchartered waters in Australia and the US


The debate over the patentability of isolated DNA has raged around the world. Tania Obranovich compares the two Myriad decisions from the highest courts in Australia and the US and explains how the Australian decision has called into question what had long been thought of as a fundamental pillar of Australian patent law

Myriad's BRCA patents, which claim both breast cancer diagnostic methods and the isolated BRCA DNA molecules, have courted significant controversy both in Australia and the US in recent years. Extensive judicial consideration in relation to the patent eligibility of isolated...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

profile

Managing IP

ManagingIP

ManagingIP profile

RT @mdloney: Michael Shore, the lawyer behind Allergan’s controversial transfer of patents to a Native American tribe, vowed to "take a wre…

Nov 22 2017 07:33 ·  reply ·  retweet ·  favourite
ManagingIP profile

Our weekly IP news round-up includes stories about Finjan, Blue Coat, Fox Television, design patents, Polaroid, Fuj… https://t.co/dOtK14m74v

Nov 22 2017 02:01 ·  reply ·  retweet ·  favourite
ManagingIP profile

Confidentiality clubs becoming more common in Indian patent disputes https://t.co/VcVqY6V4CY The Delhi High Court r… https://t.co/qkhIzENcAw

Nov 22 2017 10:00 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


null null null

null null null

October 2017

Courts grapple with scope of patent protection

The Supreme Court’s decision in Actavis v Eli Lilly introduced a doctrine of equivalents and arguably also established a doctrine of prosecution history estoppel in the UK. We look at the law across Europe, and the impact the decision might have. Kingsley Egbuonu, Michael Loney and James Nurton set the scene



Most read articles

Supplements